Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Am J Prev Med. 2013 Apr;44(4 0 4):S324–S332. doi: 10.1016/j.amepre.2012.12.015

Table 2.

Measures of adiposity and metabolic outcomes of HELP PD over 2 years by treatment group with tests for effect during the second year, M (SE)

Variable Group Baseline 6-month 12-month 18-month 24-month Adjusted means over 18 and 24 months of follow-upa p-value
Weight (kg) Control 93.02 (1.32) 91.55 (1.38) 90.93 (1.37) 90.93 (1.39) 92.23 (1.43) 92.80 (0.50)
LWL 94.38 (1.20) 87.14 (1.22) 87.44 (1.28) 88.33 (1.36) 88.81 (1.33) 88.61 (0.51)
Diff −4.19 (0.71) <0.001
BMI Control 32.56 (0.34) 31.96 (0.34) 31.95 (0.36) 31.81 (0.35) 32.16 (0.36) 32.42 (0.18)
LWL 32.85 (0.32) 30.38 (0.35) 30.52 (0.36) 30.76 (0.38) 30.94 (0.38) 31.02 (0.18)
Diff −1.40 (0.25) <0.001
Waistb (cm) Control 104.37 (0.87) 103.37 (0.90) 103.45 (0.89) 104.05 (0.91) 104.30 (0.48)
LWL 104.93 (0.76) 98.67 (0.84) 99.22 (0.90) 100.92 (0.93) 101.06 (0.49)
Diff −3.23 (0.69) <0.001
Glucose (mg/dL) Control 105.71 (0.82) 106.97 (0.77) 104.16 (0.99) 107.42 (0.99) 107.60 (1.08) 107.44 (0.79)
LWL 105.37 (1.02) 101.69 (0.81) 101.11 (0.84) 102.70 (0.98) 103.28 (0.96) 103.09 (0.81)
Diff −4.35 (1.14) <0.001
Insulin (μU/mL) Control 16.74 (0.81) 15.54 (1.07) 12.81 (0.64) 14.88 (1.62) 13.71 (0.78) 14.38 (0.76)
LWL 16.67 (0.79) 10.73 (0.61) 9.76 (0.46) 10.15 (0.55) 12.25 (1.02) 11.37 (0.77)
Diff −3.01 (1.08) 0.006
HOMA IR Control 4.45 (0.23) 4.18 (0.30) 3.33 (0.18) 4.11 (0.51) 3.76 (0.24) 3.96 (0.25)
LWL 4.44 (0.24) 2.77 (0.18) 2.48 (0.13) 2.63 (0.16) 3.26 (0.31) 2.99 (0.25)
Diff −0.97 (0.35) 0.006
Weight loss (%) Control 0.00 −1.18 (0.29) −1.33 (0.39) −0.93 (0.51) −0.57 (0.55) −0.77 (0.54)
LWL 0.00 −7.52 (0.48) −7.21 (0.57) −5.82 (0.62) −5.39 (0.66) −5.35 (0.55)
Diff −4.59 (0.77) <0.001
a

Least-square means from a repeated-measures ANCOVA using the baseline value as a covariate; p-values represent the between-group comparison of the average of the 18- and 24-month means

b

Waist not measured at the 18-month visit

Diff, difference; HELP-PD, Healthy Living Partnerships to Prevent Diabetes; HOMA IR, homeostasis model of insulin resistance; LWL, lifestyle weight-loss intervention; UC, enhanced usual care intervention